Athenex, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Buffalo NY United States (2003)

Organization Overview

First Clinical Trial
2007
NCT00658970
First Marketed Drug
2003
bumetanide (bumex)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ATHENEX | Athenex, Inc. | ATHENEX INC | Kinex Pharmaceutical | Kinex Pharmaceuticals | Kinex Pharmaceuticals Inc | Maxinase Life Sciences Ltd.